T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety profile in patients with two types of advanced thyroid cancer, according to ...

University of Miami Miller School of Medicine researchers have identified molecular evidence linking human papillomavirus ...